Syngenta Deal as an example of expansion from emerging countries

Syngenta Deal as an example of expansion from emerging countries

In addition to the previous blog post, I put here a link to a paper that was written in 2010 about the expansion of companies from emerging countries expanding in global markets:

http://mr-int.ch/images/documents/global_emerging_companies.pdf

Was I already prophet in my own country?…

Syngenta: bad news

Syngenta: bad news

Today Syngenta announced that, for 43 billion dollars, it will be acquired by ChemChina.

Why is it bad news ?

 

 

  1. because Syngenta management has no one ounce of courage to drive the company in an Read more

Syngenta : an unusual debate

Syngenta : an unusual debate

While agribusiness is in a low phase of its cycle, the Syngenta situation is far from being resolved. On one hand, financial results are not at the height of [too greedy?] expectations of shareholders, and on the strategic side Read more

Syngenta without direction

Syngenta without direction

Once again, discussions are on-going about a possible acquisition of Syngenta, now by ChemChina or whoever else, or a merger with nobody knows who.

When this company was created as a merged spin-off of the agricultural businesses from AstraZeneca Read more

Predicament of Ag Inputs Manufacturers

Predicament of Ag Inputs Manufacturers

Something in relation with my business relations (www.mr-int.ch).

Every decade or so, any industry seems to have to undertake a fundamental shake-out. This is now the case of the pesticides-cum-seeds sector. Large strategic, financial, regulatory, and political Read more

News: Monsanto invests in Dicamba production

News: Monsanto invests in Dicamba production

In need of chemistry, the genetically modified company Monsanto is looking for the saving grace of older herbicide molecules. This is understandable: weeds show some resistance to glyphosate.

In parallel, its egotistic management wants to acquire Syngenta for its Read more

Syngenta: good reasons to refuse the Monsanto offer

Syngenta: good reasons to refuse the Monsanto offer
A deal is a deal, good or bad. For the shareholders of both companies, two groups to which I don’t belong, the proposed merger may well be a bad deal. Neither will it be any good for the employees. There are three reason to this negative assessment –financial, operative, and strategic– that don’t point to valuable synergies. Read more

Toxicology: expert disorientation

Toxicology: expert disorientation

In matters such as climate, human health, or other existential worries, no one day goes on without us being served the news of an imminent disaster, a scandal, or a terrorizing situation.

So, recently, antieverything groups were delighted that Read more